2030년까지 중동 및 아프리카 생물생산 시장 예측 - 지역 분석 - 제품별(생물의약품 및 바이오시밀러, 백신, 세포 및 유전자 치료법, 핵산 치료제 등), 용도(류마티스 관절염, 혈액 질환, 암, 당뇨병, 심혈관 질환, 및 기타), 장비(업스트림 장비, 다운스트림 장비, 생물반응기, 소모품 및 부속품) 및 최종 사용자(바이오의약품 회사, 계약 제조 조직 및 기타)
자동화된 세포 치료 제조로의 전환으로 중동 및 아프리카 생물생산 시장 강화
자동화는 오염 위험 감소, 일관성이 향상되고 생산 비용이 절감됩니다. 많은 회사에서 Lonza Cocoon 및 Miltenyi의 CliniMACS Prodigy 시스템과 같은 자동화를 지원하는 장치를 제공하고 있으며 단일 시스템 내에서 CAR-T 프로세스에 대한 대부분의 순차적 장치 작업을 자동화할 수 있도록 설계되었습니다. 전 세계적으로 세포치료제의 수가 증가함에 따라 세포치료제 생산이 소량에서 대량으로 전환되었습니다. 또한 학술 및 임상 환경에서 대량 생산 및 상업화에 이르기까지 세포 치료가 진화함에 따라 제조 자동화에 대한 수요가 증가하고 있습니다. 세포 치료 분야의 연구 활동이 증가하면서 고급 제조 솔루션에 대한 수요가 증가했습니다. 이를 고려하여 많은 업체들이 학술 연구원과 대규모 생명공학 기업의 디지털 요구 사항을 충족하는 제품을 제공하고 있습니다. 예를 들어, 2019년 5월 GE Healthcare는 전체 세포 치료 워크플로우를 지원하기 위해 Chronicle 웹 애플리케이션을 출시했습니다. Chronicle 자동화 소프트웨어는 복잡한 세포 치료 공정 개발 및 제조를 최적화하도록 설계된 우수제조관리기준(GMP)을 준수하는 디지털 솔루션입니다.
또한 기업들은 세포 치료의 자동화를 위한 전략 및 기술 개발에 착수하고 있습니다. 예를 들어, 2020년 7월 Thermo Fisher Scientific Inc.와 Lyell Immunopharma는 암 환자를 위한 효과적인 세포 치료법을 설계하기 위한 프로세스를 개발하고 제조하기 위해 파트너십을 맺었습니다. 이번 파트너십을 통해 양사는 T세포의 적합성을 개선하고 시약, 소모품, 기기와 함께 cGMP(현행 우수제조관리기준) 준수 플랫폼(시스템 및 소프트웨어) 통합 개발을 지원하는 것을 목표로 하고 있다. 따라서 세포치료제 제조업체들 사이에서 자동화 채택이 증가하면서 시장이 주도될 것으로 예상됩니다.
중동 및 아프리카 생물생산 시장 개요
중동 및 아프리카의 생물생산 시장에는 UAE, 사우디아라비아, 남아프리카 및 기타 중동 및 아프리카에 대한 국가 수준의 분석이 포함됩니다. 생물생산 시장의 성장은 정부 정책 변화, 민간-공공 파트너십 증가, 의료 인프라 개선에 기인할 수 있습니다. 더욱이, 진보되고 효과적인 세포 치료법에 대한 수요가 증가함에 따라 시장 성장이 촉진되고 있습니다.
국제 약리경제학 및 결과 연구 학회(ISPOR)에 따르면, 심혈관 질환은 2020년 사우디아라비아에서 가장 큰 사망 원인으로 전체 사망 사례의 45.7%를 차지했습니다. 또한, 사우디아라비아에서는 건강에 해로운 식습관과 앉아서 생활하는 생활 방식으로 인해 당뇨병 발병률이 높습니다. IDF에 따르면 사우디아라비아의 당뇨병 발병률은 2021년 8%~22%였습니다. 당뇨병을 유발하는 주요 요인은 비만, 건강에 해로운 생활 방식, 유전적 감수성입니다. 전국적인 조사에 따르면 사우디아라비아는 2022년 심혈관 질환 유병률이 5.5%였다. 따라서 사우디아라비아의 심혈관 질환 및 당뇨병 발병률 증가가 바이오생산 시장의 성장을 주도하고 있다.
중동 및 아프리카 생물생산 시장 수익 및 예측(미화 백만 달러)
중동 및 아프리카 생물생산 시장 세분화
중동 및 아프리카 생물생산 시장은 제품, 응용 프로그램, 장비, 최종 사용자로 분류됩니다. , 및 국가.
제품을 기준으로 중동 및 아프리카 생물생산 시장은 생물의약품 및 바이오시밀러, 백신, 세포 및 유전자 치료, 핵산 치료제 등으로 분류됩니다. 생물의약품 및 바이오시밀러 부문은 2022년 중동 및 아프리카 생물생산 시장에서 가장 큰 점유율을 차지했습니다.
적용 측면에서 중동 및 아프리카 생물생산 시장은 류마티스 관절염, 혈액 질환, 암, 당뇨병, 심혈관 질환, 다른 사람. 암 부문은 2022년 가장 큰 중동 및 아프리카 생물생산 시장 점유율을 차지했습니다.
장비별로 중동 및 아프리카 생물생산 시장은 업스트림 장비, 다운스트림 장비, 생물반응기, 소모품 및 액세서리로 구분됩니다. 소모품 및 액세서리 부문은 2022년 중동 및 아프리카 생물생산 시장에서 가장 큰 점유율을 차지했습니다.
최종 사용자 측면에서 중동 및 아프리카 생물생산 시장은 생물의약품 회사, 계약 제조 조직 등으로 분류됩니다. 바이오제약 회사 부문은 2022년에 가장 큰 중동 및 아프리카 바이오생산 시장 점유율을 차지했습니다.
국가별로 중동 및 아프리카 바이오생산 시장은 사우디아라비아, UAE, 남아프리카공화국, 기타 중동 및 아프리카 지역으로 분류됩니다. . 사우디아라비아는 2022년 중동 및 아프리카 생물생산 시장 점유율을 장악했습니다.
Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd 및 Bio-Rad Laboratories Inc. 중동 및 아프리카 생물생산 시장에서 활동하는 주요 기업 중 일부입니다.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Middle East & Africa Bioproduction Market
10.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 Saudi Arabia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 Saudi Arabia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Saudi Arabia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 Saudi Arabia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 Saudi Arabia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 South Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 South Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 South Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 South Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 South Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 UAE: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 UAE: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 UAE: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 UAE: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 UAE: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Rest of Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Rest of Middle East & Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1. Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Bioproduction Market Segmentation
Table 2. Middle East & Africa Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Bioproduction Market, For Bioreactors by Equipment by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. South Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. South Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. UAE Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 17. UAE Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Middle East & Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 24. Recent Organic Growth Strategies in the Bioproduction Market
Table 25. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Middle East & Africa Bioproduction Market Segmentation, By Country
Figure 2. Middle East & Africa Bioproduction Market: Key Industry Dynamics
Figure 3. Middle East & Africa Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Middle East & Africa: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Middle East & Africa: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.